{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-034627","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.992649+00:00","generated_at":"2026-06-10T07:34:08.349752+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Qualigen Therapeutics enters waiver with Alpha Capital to pay October 2023 debenture redemption in shares","bullets":["Waiver applies to $3.3M 8% Senior Convertible Debenture issued Dec 22, 2022.","Alpha consents to paying the October 2023 Monthly Redemption Amount in Conversion Shares.","Alpha waives the Equity Conditions requirement for the October Payment.","No other terms of the Debenture are amended.","Effective September 22, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-034627","json":"https://secwatch.observer/filing/0001493152-23-034627.json","markdown":"https://secwatch.observer/filing/0001493152-23-034627.md","text":"https://secwatch.observer/filing/0001493152-23-034627.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/0001493152-23-034627-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:34:08.349752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52224001f067e4885a0716b50673218c9674147b","claim":"AIxCrypto Holdings, Inc. entered into Waiver with Alpha Capital Anstalt valued at $3,300,000 (effective 2023-09-22).","evidence_excerpt":"On September 22, 2023, Qualigen Therapeutics, Inc. (the “Company”) entered into a consent and waiver (the “Waiver”) with Alpha Capital Anstalt (“Alpha”) with respect to the 8% Senior Convertible Debenture in the aggregate principal amount of $3,300,000 issued by the Company to Alpha on December 22, 2022 (the “Debenture”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/0001493152-23-034627-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Alpha Capital Anstalt"},{"label":"Value","value":"$3,300,000"},{"label":"Effective","value":"2023-09-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}